NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
35 hedge funds and large institutions have $5.35M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less capital invested
Capital invested by funds: $8.63M → $5.35M (-$3.28M)
46% less call options, than puts
Call options by funds: $46K | Put options by funds: $85K
Holders
35
Holding in Top 10
1
Calls
$46K
Puts
$85K
Top Buyers
| 1 | +$383K | |
| 2 | +$320K | |
| 3 | +$202K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$37.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$24.4K |
Top Sellers
| 1 | -$897K | |
| 2 | -$389K | |
| 3 | -$315K | |
| 4 |
Millennium Management
New York
|
-$29.5K |
| 5 |
BlackRock
New York
|
-$23K |